GELSYN-3
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Jun 2023)
What this means for you
Registered since 17 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86888721
- Registration number
- 5125702
- Mark type
- Stylized text
- Filed
- 27 Jan 2016
- Published for opposition
- 14 Jun 2016
- Registered
- 17 Jan 2017
- Attorney of record
- MICHELLE E. TOCHTROP
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, arthrosis, and reduced mobility due to degenerative disease, post-traumatic disease or joint alteration; Syringes sold filled with pharmaceutical preparation containing hyaluronic acid
- Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body
Owner
- BIOVENTUS LLC, DURHAM, NC, US
- BIOVENTUS LLC, DURHAM, NC, US
- IBSA INSTITUT BIOCHIMIQUE S.A., CH-6903 LUGANO, CH
- IBSA INSTITUT BIOCHIMIQUE S.A., CH-6903 LUGANO, CH
Prosecution history
- 23 Jan 2026 — TEAS SECTION 8 & 9 RECEIVED
- 17 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2023 — TEAS SECTION 8 & 15 RECEIVED
- 23 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Dec 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Dec 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Nov 2016 — USE AMENDMENT FILED